Elevance Health price to free cash flow ELV

Market value divided by free cash flow over the last twelve months, since 2010.

Today, Oct 23, 2026: 15.2×
10-year median: 14.8×
Against its 10-year history: 52nd; percentile: 0 is its lowest day, 100 its highest
10-year range: 6.4× to 157×
Peer median: 7.0×

Elevance Health's price to free cash flow is 15.2× as of Oct 23, 2026.

That is above its ten-year median of 14.8×, close to the middle of its last ten years.

Over that time it ranged from 6.4× in Sep 2020 to 157× in Aug 2024.

The median for 6 health insurers of a similar size is 7.0×.

Price to free cash flow over time

median 14.8×

The dashed line is the 10-year median and the shaded band the middle half of its days.

Open the interactive chart, with overlays and comparisons

Year by year

Year	End of year	Low	High
2026 so far	15.2×	11.6×	24.1×
2025	20.6×	11.6×	107×
2024	98.8×	13.2×	157×
2023	13.4×	9.1×	16.2×
2022	11.8×	11.1×	17.3×
2021	11.9×	7.5×	16.6×
2020	11.2×	6.4×	18.8×
2019	18.7×	16.1×	90.4×
2018	75.2×	11.7×	84.2×
2017	11.4×	10.7×	17.0×
2016	11.7×	9.6×	13.4×
2015	13.2×	12.0×	15.9×
2014	12.7×	8.6×	12.8×
2013	13.2×	8.5×	13.7×
2012	12.3×	6.5×	12.6×
2011	6.7×	6.4×	61.2×
2010	53.3×	18.5×	55.0×

Against its peers

Companies in Medical - Healthcare Plans nearest Elevance Health's size, closest first, today.

Company	Price to free cash flow
ELVElevance Health	15.2×
CICigna	n/m
CVSCVS Health	10.2×
HUMHumana	26.0×
CNCCentene	3.9×
UNHUnitedHealth	n/m
OSCROscar Health	2.2×
Peer median	7.0×

What the price to free cash flow tells you

Market value divided by free cash flow: the cash left after running the business and paying for equipment. Cash is harder to manage than accounting earnings, so many investors trust this more than PE.

Lumpy: a big year of building factories drops cash flow and inflates the ratio without the business getting worse.

More on Elevance Health

Valuation data, not investment advice. Prices as of Oct 23, 2026. Reported figures come from the company's filings with the SEC.